Esperion Therapeutics, Inc. logo ESPR - Esperion Therapeutics, Inc.

Inactive Ticker ESPR is not actively trading. Quotes and analytics may be stale.
Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 8
HOLD 15
SELL 2
STRONG
SELL
0
| PRICE TARGET: $3.19 DETAILS
HIGH: $3.28
LOW: $3.16
MEDIAN: $3.16
CONSENSUS: $3.19
UPSIDE: 0.31%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Stable Earnings Power

AlphaQuality — archetype-weighted quantitative grade

F 26.6 / 100 pillar composite

Composite Grade

Composite of six pillars weighted for stable earnings power businesses. Purely quantitative — the six pillars score only reported financials, no analyst input.

⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 26.6 pillar composite because hard gates always win. Use the pillar breakdown below to see where the underlying numbers sit.

Profitability

Weight: 20%
D- 30.0
  • 5yr Avg ROIC -98.2% 0/100
  • Operating Margin Trend +86.21 pp/yr 100/100
Contributes 6.0 pts toward composite.

Capital Efficiency

Weight: 15%
F 0.0
  • 5yr Share-Count CAGR 49.9% 0/100
Contributes 0.0 pts toward composite.

Growth Quality

Weight: 15%
B+ 77.5
  • 5yr Revenue CAGR 12.1% 85/100
  • Revenue-Growth Years (5) 3/5 60/100
Contributes 11.6 pts toward composite.

Cash Generation

Weight: 15%
F 0.0
  • 5yr FCF Margin -139.0% 0/100
  • 5yr FCF/NI Conversion 0.00x 0/100
Contributes 0.0 pts toward composite.

Balance Sheet

Weight: 20%
F 6.6
  • Net Debt / EBITDA 5.95x 8/100
  • Interest Coverage (EBIT/Int) 0.75x 10/100
  • Altman Z-Score -2.63 0/100
Contributes 1.3 pts toward composite.

Stability

Weight: 15%
C 51.5
  • Negative-Revenue Years (5) 2/5 60/100
  • Piotroski F-Score 4 44/100
Contributes 7.7 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Dumping

1 of 3 gurus held; 1 new buy; 3 full exits.

Holders
1 -2
Avg Δ position
New buys
1
Full exits
3
As of Q2 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (20%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Share-Count CAGR
  • Growth Quality (15%) — 5yr Revenue CAGR, Revenue-Growth Years (5)
  • Cash Generation (15%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (20%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (15%) — Negative-Revenue Years (5), Piotroski F-Score

The six pillars read only reported financial-statement fields — no analyst targets or consensus ratings. The archetype that picks which pillar formulas apply is not fully price-free, though: it can route a company to the distressed/ungradable archetype based on price vs. its 52-week high, and beta affects one classification check. A minimum of 5 fiscal years of audited statements is required. Insurers and banks are graded on their own methodology — insurers on loss ratio, its trend and stability, and premiums-to-surplus; banks on the efficiency ratio, its trend and stability, and equity-to-assets — rather than on industrial margin/ROIC signals. Distressed, highly leveraged infrastructure, asset-manager, and other financial businesses are declared ungradable rather than forced into a numeric score.